Gene · 977
Papers2,195
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,195
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Synergizing Nanosensor-Enhanced Wearable Devices with Machine Learning for Precision Health Management Benefiting Older Adult Populations. | ACS Nano | 2025 | 40657801 | PubTator, text mining | PubMed |
| Systematic Evaluation of Isolation Techniques and Freeze-Thaw Effects on Plasma Extracellular Vesicle Heterogeneity and Subpopulation Profiling. | J Extracell Biol | 2025 | 40575388 | PubTator, text mining | PubMed |
| Key mediators of the efficacy of mesenchymal stem cells on in vivo disease models. | Cell Transplant | 2025 | 40560652 | PubTator, text mining | PubMed |
| Mechanism of umbilical cord mesenchymal stem cells in the expansion of umbilical cord blood-derived hematopoietic stem cells in vitro. | J Int Med Res | 2025 | 40552658 | PubTator, text mining | PubMed |
| A Novel Null Allele of the RAPH Blood Group System. | Transfusion | 2025 | 40511599 | PubTator, text mining | PubMed |
| Integrated muti-omics data and machine learning reveal CD151 as a key biomarker inducing chemoresistance in metabolic syndrome-related early-onset left-sided colorectal cancer. | Funct Integr Genomics | 2025 | 40484863 | PubTator, text mining | PubMed |
| CD151 interacts with integrin beta 2 in B cell lymphomas. | Cell Mol Life Sci | 2025 | 40464949 | PubTator, text mining | PubMed |
| CD151 Promotes Cancer Progression in Triple-Negative Breast Cancer by Inducing EMT through the MAPK Signaling Pathway. | Breast Cancer (Dove Med Press) | 2025 | 40458675 | PubTator, text mining | PubMed |
| Natural killer cells adopt an activated and decidual-like phenotype after autologous hematopoietic stem cell transplantation in children with cancer. | Commun Med (Lond) | 2025 | 40437214 | PubTator, text mining | PubMed |
| Characterization of small extracellular vesicles from ovarian cancer patients and pre-diagnostic patient samples: Evidence from the Danish blood donor study. | PLoS One | 2025 | 40372993 | PubTator, text mining | PubMed |
| [Typical strategy and research progress of efficient isolation methods of exosomes based on affinity interaction]. | Se Pu | 2025 | 40331606 | PubTator, text mining | PubMed |
| Extracellular vesicles adhere to cells primarily by interactions of integrins and GM1 with laminin. | J Cell Biol | 2025 | 40304687 | PubTator, text mining | PubMed |
| Migrasomes as intercellular messengers: potential in the pathological mechanism, diagnosis and treatment of clinical diseases. | J Nanobiotechnology | 2025 | 40254563 | PubTator, text mining | PubMed |
| ERBB4 as a therapeutic target in aortic dissection: Implications for cell-based therapies in vascular regeneration. | Biomol Biomed | 2025 | 40227858 | PubTator, text mining | PubMed |
| The controversial role of CD151 in different solid tumors: promoter or suppressor? | Cancer Cell Int | 2025 | 40119419 | PubTator, text mining | PubMed |
| Trichomonas vaginalis adhesion protein 33 (TvAP33) promotes HPV infection by upregulating the expression of HPV membrane receptor molecules. | Acta Trop | 2025 | 40057257 | PubTator, text mining | PubMed |
| Mosaic loss of Y chromosome and mortality after coronary angiography. | Eur Heart J | 2025 | 39935193 | PubTator, text mining | PubMed |
| Retraction Note: Tspan8 and Tspan8/CD151 knockout mice unravel the contribution of tumor and host exosomes to tumor progression. | J Exp Clin Cancer Res | 2025 | 39819382 | PubTator, text mining | PubMed |
| Role of the transmembrane polar residues on CD151 in cholesterol binding. | J Biomol Struct Dyn | 2025 | 39743780 | PubTator, text mining | PubMed |
| Dengue infection changes the expressions of CD154 and CD148 in human platelets. | Virus Res | 2025 | 39710119 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/977/papers?page=4